The federal government is taking one of its biggest steps yet toward recognizing medical marijuana businesses under federal law. In recent weeks, the Drug Enforcement Administration (DEA) launched new registration forms and an online application portal for state-licensed medical marijuana dispensaries and related cannabis businesses. The move follows a major policy shift by the U.S. […]

Rescheduling marijuana to Schedule III marks a pivotal shift in federal drug policy by acknowledging its accepted medical use and moderate to low potential for dependence. This change promises tax relief, streamlined research, improved banking access, and clearer regulatory pathways for medical marijuana under the Controlled Substances Act. The rescheduling process involves scientific review, rulemaking, […]